Education
About Us
Working with TipRanks
Follow Us
Tauns Laboratories, Inc. (JP:197A)
:197A
197A Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥418.00 - ¥733.00
Previous CloseN/A
Volume864.10K
Average Volume (3M)465.04K
Market Cap
¥56.76B
Enterprise Value¥60.57B
Total Cash (Recent Filing)¥8.58B
Total Debt (Recent Filing)¥13.63B
Price to Earnings (P/E)9.1
Beta0.48
Next Earnings
Nov 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 27, 2025Dividend Yield3.27%
Share Statistics
EPS (TTM)-3.46
Shares Outstanding103,199,776
10 Day Avg. Volume305,410
30 Day Avg. Volume465,043
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥673.00Price Target Upside20.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Tauns Laboratories, Inc. News
197A FAQ
What was Tauns Laboratories, Inc.’s price range in the past 12 months?
Tauns Laboratories, Inc. lowest stock price was ¥418.00 and its highest was ¥733.00 in the past 12 months.
What is Tauns Laboratories, Inc.’s market cap?
Tauns Laboratories, Inc.’s market cap is ¥56.76B.
When is Tauns Laboratories, Inc.’s upcoming earnings report date?
Tauns Laboratories, Inc.’s upcoming earnings report date is Nov 12, 2025 which is in 40 days.
How were Tauns Laboratories, Inc.’s earnings last quarter?
Tauns Laboratories, Inc. released its earnings results on Aug 13, 2025. The company reported -¥3.46 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.46.
Is Tauns Laboratories, Inc. overvalued?
According to Wall Street analysts Tauns Laboratories, Inc.’s price is currently Undervalued.
Does Tauns Laboratories, Inc. pay dividends?
Tauns Laboratories, Inc. pays a Semiannually dividend of ¥12 which represents an annual dividend yield of 3.27%. See more information on Tauns Laboratories, Inc. dividends here
What is Tauns Laboratories, Inc.’s EPS estimate?
Tauns Laboratories, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tauns Laboratories, Inc. have?
Tauns Laboratories, Inc. has 103,199,776 shares outstanding.
What happened to Tauns Laboratories, Inc.’s price movement after its last earnings report?
Tauns Laboratories, Inc. reported an EPS of -¥3.46 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.284%.
Which hedge fund is a major shareholder of Tauns Laboratories, Inc.?
Currently, no hedge funds are holding shares in JP:197A
Company Description
Tauns Laboratories, Inc.
Tauns Laboratories, Inc. (197A) is a company operating in the biotechnology and healthcare sector, specializing in the development, manufacturing, and distribution of diagnostic products. Its core products include in vitro diagnostic reagents and rapid testing kits used for various medical and clinical applications. The company is committed to advancing healthcare through innovative and reliable diagnostic solutions.
Technical Analysis
Fuji Pharma Co., Ltd.
―
Nippon Shinyaku Co., Ltd.
―
KYORIN Pharmaceutical Co.,Ltd.
―
ASKA Pharmaceutical Holdings Co., Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―
Options Prices
Currently, No data available
---